Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanocarrier-Enabled Melittin Therapy: Mechanistic Advances, Therapeutic Applications, and Translational Challenges.

International journal of nanomedicine·2026
Same author

Advances in Nano-Drug Delivery Systems for Osteosarcoma: From Targeting Strategies to Combating Lung Metastasis.

International journal of nanomedicine·2026
Same author

Lung macrophages in pulmonary homeostasis and disease: from basic biology to clinical applications.

Central-European journal of immunology·2026
Same author

Ethical challenges of adaptive deep brain stimulation: a multidimensional analysis through the lens of control.

Journal of medical ethics·2026
Same author

Targeted Decompression Under Local Anesthesia versus Extensive Decompression Under General Anesthesia for Octogenarians with Lumbar Degenerative Diseases: A Real-World Propensity Score-Matched Analysis.

Clinical interventions in aging·2026
Same author

Diagnosis and treatment of abdominal pain of spinal origin: a case report.

Journal of medical case reports·2026

Related Experiment Video

Updated: May 30, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Biobanks and the phantom public.

Herbert Gottweis1, Haidan Chen, Johannes Starkbaum

  • 1University of Vienna, Vienna, Austria. herbert.gottweis@univie.ac.at

Human Genetics
|July 21, 2011
PubMed
Summary
This summary is machine-generated.

Research on public perceptions of biobanks is limited, with data concentrated in few regions and often using small samples. More combined qualitative and quantitative research is needed to understand public opinion on biobanks.

More Related Videos

Creation and Maintenance of a Living Biobank - How We Do It
13:08

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Related Experiment Videos

Last Updated: May 30, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Creation and Maintenance of a Living Biobank - How We Do It
13:08

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Area of Science:

  • Biobanking and Public Engagement
  • Societal Impact of Biomedical Research
  • Governance of Health Data

Background:

  • Understanding public perceptions of biobanks is crucial for their ethical and effective operation.
  • Current research on the biobank-public relationship is geographically limited and methodologically constrained.
  • Identifying key stakeholder concerns is essential for developing robust governance strategies.

Purpose of the Study:

  • To survey existing knowledge on national publics' perceptions of biobanks.
  • To analyze the biobank-public interface and emerging governance strategies.
  • To highlight gaps in current research and propose future directions.

Main Methods:

  • Literature review of studies on public engagement with biobanks.
  • Analysis of existing survey data and governance approaches.
  • Identification of methodological limitations in current research.

Main Results:

  • Existing data on public perceptions of biobanks are concentrated in specific regions (e.g., Northern Europe, UK, US).
  • Research often relies on small-sample surveys with limited questionnaires.
  • Combined qualitative and quantitative methodologies are underutilized but important for explaining public opinion patterns.

Conclusions:

  • The "phantom biobank public(s)" remain elusive, necessitating further investigation.
  • Significant gaps exist in understanding the complex relationship between publics and biobanks.
  • There is a need for more comprehensive and methodologically diverse research to address inconsistencies and unexplored questions.